AVMA news
EPA, FDA weigh oversight overhaul for animal parasite products
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
AVMA news
Convention sessions, statement touch on environmental impact of veterinary medicine
Speakers at AVMA Convention 2023 will talk about the impacts of climate change and how environmental sustainability is an increasingly important topic…
AVMA news
Remaining medically important antimicrobials transitioning to prescription status
The Food and Drug Administration is reminding stakeholders that certain over-the-counter antimicrobial products for animals are transitioning to…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
JAVMA news
Editing Animals
Recent gene-editing technologies are being used to create mice that model human genetic diseases, Holstein cattle lacking horns, and current research…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
AVMA news
FDA warns manufacturers, distributors of unapproved antimicrobials for animals
The U.S. Food and Drug Administration (FDA) on December 14 announced it has issued nine warning letters to manufacturers and distributors of…
AVMA news
Honeybee vaccine receives conditional license from USDA
The U.S. Department of Agriculture has granted a conditional license for a vaccine to protect honeybees against American foulbrood. The only…
JAVMA news
Antimicrobial sales rise despite pending changes
Agreements between federal regulators and pharmaceutical companies are expected to reduce antimicrobial use in agriculture by the end of this year.
JAVMA news
Pig drug may be withdrawn over residues
Food and Drug Administration officials are working to rescind approval of a swine-use drug that may leave carcinogenic residues in pork.
JAVMA news
NIFA awards $2.3 million to relieve veterinary shortages
The competitive grants awarded by the Department of Agriculture’s National Institute of Food and Agriculture are funded through the new Veterinary…
JAVMA news
Q&A with Dr. Elizabeth A. Curry-Galvin
Dr. Elizabeth A. Curry-Galvin, outgoing deputy chief executive officer of the AVMA, answers questions from JAVMA News.
JAVMA news
FDA to require species-specific antimicrobial data
Pharmaceutical companies will need to give federal authorities data that could be used to compare antimicrobial consumption and
AVMA news
Nominations open for 2024 AVMA Excellence awards
Summary: The nomination period is open for the 2024 AVMA Excellence Awards. The awards program recognizes contributions by veterinarians and…
AVMA news
AVMA Steve Dale Excellence in Veterinary Media Award given to Shojai
Amy Shojai accepted the AVMA Steve Dale Excellence in Veterinary Media Award on July 15 during AVMA Convention 2023 in Denver. The award is meant to…
AVMA news
AVMA honors Kinnarney, Meyer for service with Trust
Drs. Joseph H. Kinnarney and Thomas F. Meyer received recognition for their contributions to the AVMA Trust during the President’s Reception July 14…
JAVMA news
Old, new deputy CEO see AVMA moving profession forward
What kept Dr. Elizabeth A. Curry-Galvin on the staff of the AVMA for two decades?
JAVMA news
AVMA Board elects Donlin as new CEO
Dr. Janet Donlin returns to the AVMA in September, this time in the Association’s top staff leadership spot
AVMA news
Shortage of cancer drugs having devastating effects on patients, veterinarians
Chemotherapy drugs, including cisplatin and carboplatin, have been in short supply for months. The situation is affecting animal patients and…
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
JAVMA news
Q&A with the AVMA president-elect candidates
Drs. Jan K. Strother and Michael J. Topper describe the challenges and opportunities facing the veterinary profession and explain why they’re ready to…
JAVMA news
Restrictions on medicated feeds coming to farms
By the end of this year, hundreds of antimicrobial applications for livestock will change to add veterinarian oversight and remove approval for growth…